Brief: Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
25/07/2024 12:02
July 25 (Reuters) - Predictive Oncology Inc POAI.O :
* PREDICTIVE ONCOLOGY ENTERS BIOMARKER DISCOVERY MARKET
AFTER
SUCCESSFUL RETROSPECTIVE OVARIAN CANCER STUDY YIELDS COMPELLING
RESULTS
Source text for Eikon: ID:nGNX5st8fF
Further company coverage: POAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axe Compute
See all newsBrief: Axe Compute Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Axe Compute Receives $317 Million In Customer Prepayments Under Global Ai Infrastructure Contracts
Brief: Duos Technologies Signs Five-Year, 55 MW Hosting Agreements With Axe Compute Valued At Over $500 Million
Brief: Axe Compute And Duos Technologies Enter Into Agreements For 55 MW Of New Ai Data Center Capacity Across Multiple U.S. Locations
GPU capacity provider Axe Compute's Q2 revenue surges